CLIA Chlamydia trachomatis
in human serum or plasma
Chlamydia is caused by the gram-negative, obligate intracellular bacterium Chlamydia trachomatis. Globally, it is the most prevalent sexually transmitted bacterial infection. The organism causes genitourinary infections in women and men, the disease often remains asymptomatic. Sexually active young individuals between 15 and 30 years of age are most at risk of chlamydia. The most common complications are pelvic inflammatory disease (PID) and salpingitis, conditions that can lead to infertility in both men and women and extra-uterine pregnancies. Cervical chlamydia infection is currently considered to be one of the risk factors for uterine cervix carcinoma.
Once detected, the infection is easily treated by a short course of antibiotic therapy.
Products
Advantages
- Detection of IgG, IgA or IgM antibodies to Chlamydia trachomatis
- Screening test intended for sexually active women age 25 or younger, pregnant women, and women and men at high risk
- Identification of chlamydial infection
- Intended for human serum and citrate plasma
- A mixture of highly specific recombinant antigens was used to achieve high assay specificity
- The kits are CE-IVD certified and intended for professional use
- For each CLIA kit a corresponding control set is available
| Assay time | 30 min |
| Assay stability | 30 days in-board-stability / in-use-stability until the expiration date at storage temperature 2-8 °C |
| Sample matrix | Serum, Plasma |
| Sample volume | 10 µL |
| Measuring range | 0,1-320 U/ml (IgG), 2-320 U/ml (IgA), 0,5-160 U/ml (IgM) |
| Assay/kit content | Reagent Cartridge with specific reagents for the assay, magnetic particles, calibrators |